AzarGen Biotechnologies Overview

  • Founded
  • 2003
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $3.1M
Latest Deal Amount
  • Investors
  • 2

AzarGen Biotechnologies General Information

Description

Developer of human therapeutic proteins designed to increase the survivability of premature-born infants. The company's human therapeutic proteins are made using advanced plant-based genetic engineering and synthetic biology techniques and it also offers a plant based expression technology which comprises optimal combinations of novel synthetic promoters, combined with enhancer and purification components, enabling medical professionals to offers drugs with superior clinical efficacy at low cost that can significantly improve the health status of citizens.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Social/Platform Software
Biotechnology
Primary Office
  • Natural Science Building, Room 2066
  • Merriman Avenue, Stellenbosch
  • Cape Town
  • South Africa
+27 021 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AzarGen Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 07-Jan-2016 $3.1M 00.00 Completed Startup
1. Seed Round Completed Startup
To view AzarGen Biotechnologies’s complete valuation and funding history, request access »

AzarGen Biotechnologies Executive Team (2)

Name Title Board Seat Contact Info
Mauritz Venter Ph.D Co-Founder & Chief Executive Officer
Cobus Zwiegelaar Ph.D Co-Founder, Chief-Scientist & Chief Operating Officer
To view AzarGen Biotechnologies’s complete executive team members history, request access »

AzarGen Biotechnologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AzarGen Biotechnologies Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Industrial Development Corporation of South Africa Corporate Development Minority 000 0000 000000 0
South African Government Government 000 0000 000000 0
To view AzarGen Biotechnologies’s complete investors history, request access »